Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Hisse Senetlerindeki Sıralama #30249
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Hisse Fiyatı
$1.88
Son senkronizasyon: 2026-08-18
Piyasa Değeri
$17.59M
Değişim (1 gün)
0.81%
Değişim (1 yıl)
-92.40%
Ülke
US
Ticaret Tvardi Therapeutics, Inc. (TVRD)

Kategori

Tvardi Therapeutics, Inc. (TVRD) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.83 - 2026-08-01

Gün sonu en düşük fiyat: $17.54 - 2025-04-01
Tvardi Therapeutics, Inc. için hisse fiyatı geçmişi: 2025 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 100.99%
2025 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$527.89 35.09%
US
$996.61 51.72%
NL
$115.26 -20.82%
AU
$735.86 6.07%
CH
$1.06K -5.95%
KR